Weekly Rundown: Research finds no increased autism risk from Tylenol during pregnancy New hair loss treatments, company acquisitions, artificial neurons, and more led the news this week.

https://www.drugdiscoverynews.com/weekly-rundown-research-finds-no-increased-autism-risk-from-tylenol-during-pregnancy-17129 Research finds no increased autism risk from acetaminophen during pregnancy Taking acetaminophen (Tylenol) during pregnancy does not increase the risk of autism spectrum disorder in children, according to a large population-based study from Denmark published in JAMA Pediatrics. Researchers analyzed more than 1.5 million births between 1997 and 2022 using national health registry data, including over 31,000 children exposed to acetaminophen in utero, and found autism rates of 1.8 percent among exposed children compared with three percent among those not exposed. This evidence aligns with a previous study in Sweden, published in 2024, which showed that initial signals of a small association between prenatal acetaminophen use and neurodevelopmental conditions disappeared once researchers accounted for shared familial factors using sibling-controlled analyses.